After a patient death in ongoing clinical trials, shareholders in an early-stage biopharmaceutical company filed a putative securities class action claiming that the company had made material misstatements about the health risks of its product. Goodwin represented both named defendants: the company and its chief executive officer. After the district…
Goodwin filed cert.-stage and merits-stage amicus briefs on behalf of the Securities Industry and Financial Markets Association (SIFMA) and the Chamber of Commerce of the United States of America. The question presented in the case is whether the failure to make a disclosure required by Item 303 of SEC Regulation…
After being retained to oppose a petition for certiorari, Goodwin attorneys successfully persuaded the Supreme Court to deny review in a case concerning the scope of the “on sale” bar under 35 U.S.C. § 102. Merck & Cie v. Watson Laboratories
Goodwin filed an amicus brief on behalf of its client the World Professional Association for Transgender Health in this case challenging the constitutionality of North Carolina’s H.B.2. The brief reviews current medical guidance on the treatment of gender dysphoria and argues that H.B.2 endangers the health, safety and well-being of…
Goodwin filed cert.-stage and merits-stage amicus briefs on behalf of the Business Roundtable (BRT) in three consolidated cases, all of which present the question of whether the collective-bargaining provisions of the National Labor Relations Act prohibit enforcement of an arbitration agreement requiring an employee to arbitrate claims against an employer…
Alkermes, an innovative drug manufacturer, sought FDA approval to market an injectable drug used for the treatment of schizophrenia. A competitor filed a citizen protest asking FDA to not approve the drug, on the ground that the competitor’s drug had marketing exclusivity that barred approval of the new drug application….
In this case, Goodwin attorneys persuaded the Federal Circuit to reverse a district court decision and find a patent relating to an orally disintegrating tablet formulation of vardenafil (an erectile dysfunction treatment branded as Staxyn) invalid for obviousness. The unanimous Federal Circuit decision held that the district court’s purported credibility…
Goodwin filed a Fourth Circuit amicus brief on behalf of the Chamber of Commerce of the United States of America and American Benefits Council in this ERISA case. Goodwin attorneys argued that the Fourth Circuit’s erroneous loss causation standard created by its prior opinion in this dispute was no longer…
Donnie Johnson brought a petition for habeas relief, seeking to overturn his death sentence. After the district court denied his petition, the Supreme Court decided Martinez v. Ryan, 132 S. Ct. 1309 (2012), and Trevino v. Thaler, 133 S. Ct. 1911 (2013), which raised the possibility that Johnson could be…
Two university researchers accused of research misconduct filed suit against an internationally-renowned university, alleging that the misconduct investigation was conducted in a way that violated state contract and tort law. The Goodwin team obtained a dismissal of the case on the ground that the researchers failed to exhaust their administrative…